ETFs positioned on Vertex Pharmaceuticals Incorporated

Name YTD change Weight AuM
+1.89% - 44,934 M€
+10.35% - 35,761 M€
+1.50% - 27,154 M€
+11.67% - 750 M€
+10.03% - 507 M€
-5.86% - 293 M€
-2.59% - 165 M€
+10.56% - 148 M€
+5.53% - 122 M€
-1.64% - 80 M€
+5.15% - 75 M€
+7.75% - 67 M€
+7.67% - 66 M€
-15.84% - 49 M€
-1.33% - 37 M€
+5.43% - 33 M€
+5.87% - 33 M€
+4.18% - 28 M€
+20.10%9.51% 15 M€
+27.41%9.43% 429 M€
+20.79%9.05% 1,079 M€
+20.72%9.05% 78 M€
+18.94%8.88% 9,953 M€
+18.64%8.54% 81 M€
+9.97%4.47% 7 M€
+17.44%4.4% 28 M€
+26.77%4.33% 11 M€
+34.51%4.15% 58 M€
+29.80%4.13% 87 M€
Logo Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (62.9%), Europe (28.8%) and other (8.3%).
Employees
6,400
  1. Stock Market
  2. Stocks
  3. VRTX Stock
  4. ETFs Vertex Pharmaceuticals Incorporated